Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue
Background: Targeted therapies, and more recently immunotherapy, have dramatically changed the landscape of treatments in oral cavity cancers and improved clinical outcomes. The benefit from targeted therapy and immune checkpoint inhibitors is however tampered by toxicities that affect different sit...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024002930 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|